Zobrazeno 1 - 10
of 26
pro vyhledávání: '"David J, Kane"'
Autor:
Richard, Conway, Elena, Nikiphorou, Christiana A, Demetriou, Candice, Low, Kelly, Leamy, John G, Ryan, Ronan, Kavanagh, Alexander D, Fraser, John J, Carey, Paul, O'Connell, Rachael M, Flood, Ronan H, Mullan, David J, Kane, Frances, Stafford, Philip C, Robinson, Jean W, Liew, Rebecca, Grainger, Geraldine M, McCarthy
Publikováno v:
Irish journal of medical science.
Poor COVID-19 outcomes occur with higher frequency in people with rheumatic and musculoskeletal diseases (RMD). Better understanding of the factors involved is crucial to informing patients and clinicians regarding risk mitigation.To describe COVID-1
Autor:
Sian Cregan, Monika Biniecka, Clare C. Cunningham, David J Kane, Lorna Gallagher, Ronan H Mullan, Douglas J. Veale, Ursula Fearon
Publikováno v:
Arthritis & Rheumatology. 72:896-902
OBJECTIVE To investigate a role for insulin-resistant pathways in inflammation and therapeutic targeting for disease modification in rheumatoid arthritis (RA). METHODS RA disease activity and cardiovascular risk factors, including insulin resistance
Autor:
Richard, Conway, Elena, Nikiphorou, Christiana A, Demetriou, Candice, Low, Kelly, Leamy, John G, Ryan, Ronan, Kavanagh, Alexander D, Fraser, John J, Carey, Paul, O'Connell, Rachael M, Flood, Ronan H, Mullan, David J, Kane, Nicola, Ambrose, Frances, Stafford, Philip C, Robinson, Jean W, Liew, Rebecca, Grainger, Geraldine M, McCarthy, Guillermo, Quiceno
Publikováno v:
2022, ' Temporal trends in COVID-19 outcomes in people with rheumatic diseases in Ireland : data from the COVID-19 Global Rheumatology Alliance registry ', Rheumatology, vol. 61, no. SI2, pp. SI151-SI156 . https://doi.org/10.1093/rheumatology/keac142
Objectives Although evidence is accumulating globally, data on outcomes in rheumatic disease and COVID-19 in Ireland are limited. We used data from the COVID-19 Global Rheumatology Alliance (C19-GRA) to describe time-varying COVID-19 outcomes for peo
Publikováno v:
Annals of the Rheumatic Diseases. 80:282.1-282
Background:Emerging evidence that the joints of asymptomatic hyperuricaemic individuals contain monosodium urate (MSU) deposits and that alternative presentations of foot pain occur in hyperuricaemia suggests that preclinical phases may occur prior t
Publikováno v:
Annals of the Rheumatic Diseases. 80:291.3-291
Background:Inflammatory arthritis (IA) is a complex life-long disease with negative consequences on occupational performance and significant impact on meaningful life roles. International guidelines for the clinical management of IA consistently reco
Publikováno v:
Annals of the Rheumatic Diseases
The recently published Global Rheumatology Alliance (GRA) physician-reported registry provides important information on COVID-19 disease morbidity patterns including characteristics associated with hospitalisation for patients with inflammatory rheum
Publikováno v:
Annals of the Rheumatic Diseases. 79:1238.1-1239
Background:Acute gouty arthritis most commonly initially affects the first metatarsophalangeal joint (MT1). (1) Musculoskeletal ultrasound (US) is a reliable tool for detecting monosodium urate crystal (MSU) deposition in gout and hyperuricemia with
Publikováno v:
Annals of the rheumatic diseases. 78(4)
Gout, which is caused by monosodium urate (MSU) deposition within joints in the presence of hyperuricaemia, is now the leading cause of inflammatory arthritis within developed countries.1 2 Despite recent observations that urate-lowering therapy (ULT
Publikováno v:
Abstracts Accepted for Publication.
Background Inflammatory arthritis strongly correlates with work disability. Treatment guidelines recommend work support but data are lacking on rheumatology clinicians9 perspectives on work referral and extent of work support within current rheumatol
Publikováno v:
Musculoskeletal care. 16(1)